Rupee falls 5 paise to 88.16 against US dollar in early trade

On Wednesday (September 10), the rupee recovered slightly from its record low level and ended with a gain of 4 paise at 88.11 against the US dollar.

On Wednesday (September 10), the rupee recovered slightly from its record low level and ended with a gain of 4 paise at 88.11 against the US dollar.

Oracle Corp reported strong earnings for the quarter and stronger commentary from the management over the future of its cloud infrastructure business.

With an investment of ₹50 crore and production capacity of 60,000 MTPA, a new Crash Barrier manufacturing facility is planned for Sambalpur to serve the South and West markets.

As of Wednesday’s closing, Tega’s market capitalisation stood at ₹13,800 crore. The acquisition will be done through a special purpose vehicle, in which Tega will hold 77%, while Apollo Funds will have a 23% stake.

JLR, which contributes nearly 70% of Tata Motors’ consolidated revenue, confirmed that the attack had affected “some data” and forced an extension of its system shutdown.

Buyers in Kotak Mahindra Bank’s block deal included Abu Dhabi Investment Authority, Goldman Sachs, BlackRock Global Funds, among others. Japan’s Sumitomo Mitsui Banking Corp was the official seller in the transaction.

TCS’s last share buyback concluded in December 2023. Instead of paying a large special dividend in Q3FY26, CLSA believes the company may opt for a tender offer-style buyback.

Treasuries were steady after a rally across the curve Wednesday, while Australian and New Zealand government bonds rose Thursday. An index of the dollar was little changed while the yen strengthened against the greenback early Thursday.

Sensex Today | Stock Market LIVE Updates: The Nifty did cross 25,000 intraday on Wednesday, but could not hold on to those levels, eventually closing below that mark. The participation of the Nifty Bank would give the bulls some comfort,…

The acquisition strengthens Dr. Reddy’s Central Nervous System (CNS) Portfolio in India and Emerging Markets through its foray into the antivertigo segment.